Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
11/2003
11/26/2003EP1363884A2 Pyridine-substituted benzanilides as potassium ion channel openers
11/26/2003EP1363883A1 Hydroxy-substituted n-alkoxy hindered amines and compositions stabilized therewith
11/26/2003EP1363881A2 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
11/26/2003EP1363873A2 Peptide deformylase inhibitors
11/26/2003EP1363705A1 Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
11/26/2003EP1363702A1 Methods of inhibiting kinases
11/26/2003EP1363638A2 Use of gal3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
11/26/2003EP1363637A1 Pyrimidine compounds and methods for making and using the same
11/26/2003EP1363635A1 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
11/26/2003EP1363632A1 Receptor selective cannabimimetic aminoalkylindoles
11/26/2003EP1363631A2 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
11/26/2003EP1363630A2 Kappa opioid receptor ligands
11/26/2003EP1238977B1 Process for the preparation of a pyridinemethanol compound
11/26/2003EP1202987B1 Quinoline derivatives and their use as antibacterial agents
11/26/2003EP1000046B1 Piperazine derivatives active on the lower urinary tract
11/26/2003EP1000028B1 Gastrokinetic monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
11/26/2003EP0757038B1 Benzamide compound and medicinal use thereof
11/26/2003EP0689436B1 Taxanes not having an oxo group at c-9 and pharmaceutical compositions containing same
11/26/2003EP0673937B1 Bicyclic heterocyclic sulfonamide and sulfonic ester derivatives
11/26/2003CN1458929A Chemokine receptor binding heterocyclic compounds
11/26/2003CN1458924A Pyridazinones and triazinones and medicinal use thereof
11/26/2003CN1458923A Substituted amino-aza-cycloalkanes useful against malaria
11/26/2003CN1458922A Urea derivative and adhesive-molecule inhibitor containing same as ctive ingredient
11/26/2003CN1458143A Process for preparing N-aroyl-L-glutaminic acid
11/26/2003CN1128797C Farnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with N- or C- linked imidazoles
11/26/2003CN1128790C 4-hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents
11/26/2003CN1128788C Benzyl(idene)-lactam derivatives, their prepn. and their use as selective(ant) agonists of 5-HT 1A and/or 5-HT 1D receptors
11/26/2003CN1128617C Preparation method for medicinal composition containing triazolyl derivative
11/25/2003USRE38329 Contrast agents for magnetic resonance imaging
11/25/2003US6653481 Used as calcium channel blockers
11/25/2003US6653478 Substituted benzimidazol-2-ones as vasopressin receptor antagonists and neuropeptide Y modulators
11/25/2003US6653338 FSH mimetics for the treatment of infertility
11/25/2003US6653334 Benzoxazole compound and pharmaceutical composition containing the same
11/25/2003US6653329 Granulated pharmaceutical formulations and methods for making the same
11/25/2003US6653323 Aryl aniline β2 adrenergic receptor agonists
11/25/2003US6653316 Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade
11/25/2003US6653313 1,4-dihydropyridine compounds as bradykinin antagonists
11/25/2003US6653307 1-aryl-4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents
11/25/2003US6653306 Epoxy-steroidal aldosterone antagonist and angiotensin II antagonist combination therapy
11/25/2003US6653304 Antiarthritic agents; skin disorders; anticarcinogenic agents
11/25/2003US6653302 Quinoline and quinazoline compounds useful in therapy
11/25/2003US6653301 For therapy of cancer, diabetes and Alzheimer's disease
11/25/2003US6653300 Pyrazole compounds useful as protein kinase inhibitors
11/20/2003WO2003095982A1 Wavy interface mixer
11/20/2003WO2003095449A1 Small molecules for inhibition of function and drug delivery to leukocytes
11/20/2003WO2003095448A1 Pyridinyl amino pyrimidine derivatives useful for treating hyper-proliferative disorders
11/20/2003WO2003095447A1 Process for the preparation of a hydrate of an anthranilic acid derivative
11/20/2003WO2003095433A1 Hexahydro-pyridazine-3-carboxylic acid derivatives, pharmaceutical compositions containing same and preparation methods thereof
11/20/2003WO2003095432A1 Benzimidazole derivatives
11/20/2003WO2003095430A1 Substituted pyrazolyl compounds for the treatment of inflammation
11/20/2003WO2003095429A1 Active substances for the treatment, diagnosis and prophylaxis of diseases in which abnormal protein structures occur
11/20/2003WO2003095426A1 Novel enantiomers of tetrahydroisoquinoline derivatives and their pharmaceutically acceptable salts, their preparations and pharmaceutical compositions
11/20/2003WO2003094919A2 Novel crystalline forms of gatifloxacin
11/20/2003WO2003094918A1 Substituted piperazine as melanocortin receptors ligands
11/20/2003WO2003094904A1 Methods and compositions for the treatment of graft failure
11/20/2003WO2003094861A2 Bis-benzimidazoles and related compounds as potassium channel modulators
11/20/2003WO2003094853A2 Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists
11/20/2003WO2003094845A2 Pyridine-based thyroid receptor ligands
11/20/2003WO2003087062A3 4-(heterocyclyl)-benzenesulfoximine compounds for the treatment of inflammation
11/20/2003WO2003051276A3 Therapeutic heterocycles
11/20/2003WO2003048130A3 Peroxisome proliferator activated receptor agonists
11/20/2003WO2003032984A8 2-phenyl benzimidazoles and imidazo-[4,5]-pyridines as cdsi/chk2-inhibitors and adjuvants to chemotherapy or radiation therapy in the treatment of cancer
11/20/2003WO2003029210A3 Heteroaryl substituted tetrazole modulators of metabotropic glutamate receptor-5
11/20/2003WO2003027076A3 1h-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1- antagonistic activity
11/20/2003WO2003008559A3 Novel analogs of choline for neuroprotection and cognitive enhancement in neurodegenerative disorders
11/20/2003WO2002102315A3 QUINAZOLINE AND PYRIDO[2,3-d]PYRIMIDINE INHIBITORS OF PHOSPHODIESTERASE (PDE) 7
11/20/2003WO2002100860A3 Heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as anti-bacterial agents
11/20/2003WO2002041910A3 Methods and compositions for the treatment of diseases of the eye
11/20/2003WO2002032869A8 Substituted heterocyclic compounds for treating multidrug resistance
11/20/2003US20030216574 Pyrazine based inhibitors of glycogen synthase kinase 3
11/20/2003US20030216569 Viricides; Aids therapy
11/20/2003US20030216568 Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation,compositions and use as medicaments
11/20/2003US20030216494 Free radical catalyst for addition polymer
11/20/2003US20030216460 N3 alkylated benzimidazole derivatives as MEK inhibitors
11/20/2003US20030216450 Inhibitors of dipeptidyl peptidase IV
11/20/2003US20030216441 Farnesyltransferase inhibitors
11/20/2003US20030216434 Cyclic derivatives as modulators of chemokine receptor activity
11/20/2003US20030216430 3, 4-dihydroquinolin-2(1H)-one compounds as NR2B receptor antagonists
11/20/2003US20030216428 Sexual disorders; blood disorders; osteoporosis; bone disorders
11/20/2003US20030216419 Isomeric fused pyrrolocarbazoles and isoindolones
11/20/2003US20030216417 Substituted anilino-quinoline compounds and use thereof
11/20/2003US20030216410 Administering to a cancer patient an indole-2-one derivative containing pyrrole ring as protein kinase inhibitor together with a cyclooxygenase inhibitor to treat the cancer
11/20/2003US20030216406 Pyrimidine derivatives
11/20/2003US20030216404 Hydroxamic acid derivatives
11/20/2003US20030216402 Administering to the living body a oxo-azabicyclo derivative to treat disease selected from arthritis, osteoporosis, periodontal diseases, inflammatory bowel disease, psoriasis, multiple sclerosis, asthma, cancer and macular degeneration
11/20/2003US20030216394 Etylene derivatives and pesticides containing said derivatives
11/20/2003US20030216390 Melanin concentrating hormone receptor ligands: substituted benzoimidazole analogues
11/20/2003US20030216385 Triazole derivatives
11/20/2003US20030216383 Compounds useful as reversible inhibitors of cysteine proteases
11/20/2003US20030216382 Useful for the treatment and/or prophylaxis of diseases associated with dipeptidyl peptidase, such as diabetes, particularly non-insulin dependent diabetes mellitus, and impaired glucose tolerance
11/20/2003US20030216380 Novel gamma secretase inhibitors
11/20/2003US20030216379 Substituted fused pyrazolecarboxylic acid arylamides and related compounds
11/20/2003US20030216377 Vitronectin receptor antagonist
11/20/2003US20030215527 Novel substituted benzimidazole dosage forms and method of using same
11/20/2003US20030213164 Substituted 5-aryl-2-(2-hydroxyphenyl)-2H-benzotriazole UV absorbers, compositions stabilized therewith and process for preparation thereof
11/20/2003US20030213071 Comprises mixing 5-(2,4-dimethoxyphenyl)-1,3,3-trimethyl-2-methylene-indoline and carbonyl compound (4-hydroxy-3-methoxy-benzaldehyde) for dyeing keratin fibers (wool, silk, and/or hair)
11/20/2003CA2490989A1 Methods and compositions for the treatment of graft failure
11/20/2003CA2485753A1 Benzimidazole derivatives
11/20/2003CA2485262A1 Novel crystalline forms of gatifloxacin
11/20/2003CA2485130A1 Novel enantiomers of tetrahydroisoquinoline derivatives and their pharmaceutically acceptable salts, their preparations and pharmaceutical compositions